Neuromyelitis optica - NMO

Neuromyelitis optica (NMO), also known as Devic's disease or Devic's syndrome, is an autoimmune, inflammatory disorder in which a person's own immune system attacks the optic nerves and spinal cord. This produces an inflammation of the optic nerve (optic neuritis) and the spinal cord (myelitis).

MRI Imaging of Neuromyelitis Neuromyelitis Optica
http://eradiology.bidmc.harvard.edu/LearningLab/central/Nolan.pdf

Devic’s Syndrome Neuromyelitis Optica
http://www.med.unc.edu/medicine/web/DevicsSyndrome.pdf

Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse Myelitis
http://depts.washington.edu/neurolog/seminars/journalclub/20090916_all.pdf

NMO-IgG predicts the outcome of recurrent optic neuritis
Rose-Innes_article1.pdf

Differentiate neuromyelitis optica from multiple sclerosis
http://www.bcm.edu/neurology/pdf/GrandRounds_20071116.pdf

Neuromyelitis Optica. Loss of myelin results optic neuritis & transverse myelitis
http://www.plu.edu/~tonderma/doc/concept-map-1.pdf


Free published articles:

1. Multiple sclerosis or neuromyelitis optica? Re-evaluating an 18th-century illness using 21st-century software.
2. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.
3. Treatment of neuromyelitis optica: an evidence based review.
4. Elderly-onset neuromyelitis optica which developed after the diagnosis of prostate adenocarcinoma and relapsed after a 23-valent pneumococcal polysaccharide vaccination.
5. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
6. Imaging the visual pathway in neuromyelitis optica.
7. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes.
8. Myasthenia Gravis during the Course of Neuromyelitis Optica.
9. Anti-aquaporin-4 antibody-positive neuromyelitis optica presenting with syndrome of inappropriate antidiuretic hormone secretion as an initial manifestation.
10. Neuromyelitis optica spectrum disease with positive autoimmune indices: a case report and review of the literature.
11. Optical coherence tomography in multiple sclerosis and neuromyelitis optica: an update.
12. New insights into neuromyelitis optica.
13. Neuromyelitis optica in Japanese sisters.
14. Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema.
15. Atypical presentations of neuromyelitis optica.
16. NMO-DBr: the Brazilian Neuromyelitis Optica Database System.
17. The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis.
18. Comparative brain stem lesions on MRI of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.
19. Influenza-associated monophasic neuromyelitis optica.
20. [HLA-DRB1 typing in Caucasians patients with neuromyelitis optica].
21. Current and future treatment approaches for neuromyelitis optica.
22. Recurrent acute rhombencephalomyelitis in an adult or neuromyelitis optica? Presentation of a case.
23. Relapse of neuromyelitis optica spectrum disorder associated with intravenous lidocaine.
24. Identification of peptide targets in neuromyelitis optica.
25. Pathogenic role of aquaporin antibodies in the development of neuromyelitis optica in a woman with celiac disease.
26. Repeated non-enhancing tumefactive lesions in a patient with a neuromyelitis optica spectrum disorder.
27. Recurrent spinal cord attacks in a patient with a limited form of neuromyelitis optica.
28. Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.
29. [Clinical variability in neuromyelitis optica: three case reports].
30. Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica.
31. Anti-aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implications.
32. [Magnetic resonance imaging characteristics of spinal cord lesions and brain abnormalities in Chinese patients with neuromyelitis optica].
33. Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica.
34. Absence of cortical demyelination in neuromyelitis optica.
35. Bilateral Internuclear Ophthalmoplegia in a Patient with Devic's Neuromyelitis Optica.
36. Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica.
37. Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica.
38. Neuromyelitis optica treatment: analysis of 36 patients.
39. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance.
40. Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence assays.
41. Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
42. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.
43. [Neuromyelitis optica: a clinical update].
44. Familial neuromyelitis optica.
45. Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis.
46. Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
47. NMDA receptor encephalitis mimicking seronegative neuromyelitis optica.
48. Neuromyelitis optica - an update: 2007-2009.
49. Syringomyelia in neuromyelitis optica seropositive for aquaporin-4 antibody.
50. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.